BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17185376)

  • 1. Role of hypothalamic adenosine 5'-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia.
    Alquier T; Kawashima J; Tsuji Y; Kahn BB
    Endocrinology; 2007 Mar; 148(3):1367-75. PubMed ID: 17185376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+/calmodulin-dependent protein kinase kinase is not involved in hypothalamic AMP-activated protein kinase activation by neuroglucopenia.
    Kawashima J; Alquier T; Tsuji Y; Peroni OD; Kahn BB
    PLoS One; 2012; 7(5):e36335. PubMed ID: 22590531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats.
    Han SM; Namkoong C; Jang PG; Park IS; Hong SW; Katakami H; Chun S; Kim SW; Park JY; Lee KU; Kim MS
    Diabetologia; 2005 Oct; 48(10):2170-8. PubMed ID: 16132951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
    Jørgensen SB; Wojtaszewski JF; Viollet B; Andreelli F; Birk JB; Hellsten Y; Schjerling P; Vaulont S; Neufer PD; Richter EA; Pilegaard H
    FASEB J; 2005 Jul; 19(9):1146-8. PubMed ID: 15878932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation.
    McCrimmon RJ; Fan X; Cheng H; McNay E; Chan O; Shaw M; Ding Y; Zhu W; Sherwin RS
    Diabetes; 2006 Jun; 55(6):1755-60. PubMed ID: 16731839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.
    Kim EK; Miller I; Aja S; Landree LE; Pinn M; McFadden J; Kuhajda FP; Moran TH; Ronnett GV
    J Biol Chem; 2004 May; 279(19):19970-6. PubMed ID: 15028725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
    Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
    J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A central role for neuronal adenosine 5'-monophosphate-activated protein kinase in cancer-induced anorexia.
    Ropelle ER; Pauli JR; Zecchin KG; Ueno M; de Souza CT; Morari J; Faria MC; Velloso LA; Saad MJ; Carvalheira JB
    Endocrinology; 2007 Nov; 148(11):5220-9. PubMed ID: 17717055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes.
    Fan X; Ding Y; Brown S; Zhou L; Shaw M; Vella MC; Cheng H; McNay EC; Sherwin RS; McCrimmon RJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1702-8. PubMed ID: 19357294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats.
    Shimizu H; Arima H; Watanabe M; Goto M; Banno R; Sato I; Ozaki N; Nagasaki H; Oiso Y
    Endocrinology; 2008 Sep; 149(9):4544-53. PubMed ID: 18535107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
    Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
    Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.
    Perrin C; Knauf C; Burcelin R
    Endocrinology; 2004 Sep; 145(9):4025-33. PubMed ID: 15192044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of neuronal energy status in the regulation of adenosine 5'-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior.
    Lee K; Li B; Xi X; Suh Y; Martin RJ
    Endocrinology; 2005 Jan; 146(1):3-10. PubMed ID: 15375032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol regulates effects of hindbrain activator 5-aminoimidazole-4-carboxamide-riboside administration on hypothalamic adenosine 5'-monophosphate-activated protein kinase activity and metabolic neurotransmitter mRNA and protein expression.
    Alenazi FS; Ibrahim BA; Briski KP
    J Neurosci Res; 2015 Apr; 93(4):651-9. PubMed ID: 25476093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of hindbrain AMP-activated protein kinase in glucoprivic feeding.
    Li AJ; Wang Q; Ritter S
    Diabetes; 2011 Feb; 60(2):436-42. PubMed ID: 21270255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caudal fourth ventricular administration of the AMPK activator 5-aminoimidazole-4-carboxamide-riboside regulates glucose and counterregulatory hormone profiles, dorsal vagal complex metabolosensory neuron function, and hypothalamic Fos expression.
    Ibrahim BA; Tamrakar P; Gujar AD; Cherian AK; Briski KP
    J Neurosci Res; 2013 Sep; 91(9):1226-38. PubMed ID: 23825033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.
    Cuthbertson DJ; Babraj JA; Mustard KJ; Towler MC; Green KA; Wackerhage H; Leese GP; Baar K; Thomason-Hughes M; Sutherland C; Hardie DG; Rennie MJ
    Diabetes; 2007 Aug; 56(8):2078-84. PubMed ID: 17513706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hindbrain adenosine 5'-monophosphate-activated protein kinase (AMPK) in hypothalamic AMPK and metabolic neuropeptide adaptation to recurring insulin-induced hypoglycemia in the male rat.
    Mandal SK; Shrestha PK; Alenazi FSH; Shakya M; Alhamami H; Briski KP
    Neuropeptides; 2017 Dec; 66():25-35. PubMed ID: 28823463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin signalling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo.
    Longnus SL; Ségalen C; Giudicelli J; Sajan MP; Farese RV; Van Obberghen E
    Diabetologia; 2005 Dec; 48(12):2591-601. PubMed ID: 16283248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia.
    McCrimmon RJ; Shaw M; Fan X; Cheng H; Ding Y; Vella MC; Zhou L; McNay EC; Sherwin RS
    Diabetes; 2008 Feb; 57(2):444-50. PubMed ID: 17977955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.